Report of the Select Joint Committee on Generic Drug Substitution

Report of the Select Joint Committee on Generic Drug Substitution PDF Author: Select Joint Committee on Generic Drug Substitution
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 28

Get Book Here

Book Description

Report of the Select Joint Committee on Generic Drug Substitution

Report of the Select Joint Committee on Generic Drug Substitution PDF Author: Select Joint Committee on Generic Drug Substitution
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 28

Get Book Here

Book Description


Making Medicines Affordable

Making Medicines Affordable PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235

Get Book Here

Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Hearings, Reports and Prints of the Senate Select Committee on Small Business

Hearings, Reports and Prints of the Senate Select Committee on Small Business PDF Author: United States. Congress. Senate. Select Committee on Small Business
Publisher:
ISBN:
Category : Legislative hearings
Languages : en
Pages : 1590

Get Book Here

Book Description


Generic drug entry prior to patent expiration an FTC study

Generic drug entry prior to patent expiration an FTC study PDF Author:
Publisher: DIANE Publishing
ISBN: 1428951938
Category :
Languages : en
Pages : 129

Get Book Here

Book Description


Report[s]

Report[s] PDF Author: Canada. Parliament. House of Commons. Special Committee on Drug Costs and Prices
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 86

Get Book Here

Book Description


Priorities in Health

Priorities in Health PDF Author:
Publisher: World Bank Publications
ISBN: 0821362615
Category : Medical
Languages : en
Pages : 242

Get Book Here

Book Description
"This companion guide to Disease Control Priorities in Developing Countries, 2nd edition speeds the diffusion of life-saving knowledge by distilling the contents of the larger volume into an easily read format. Policy makers, practitioners, academics, and other interested readers will get an overview of the messages and analysis in Disease Control Priorities in Developing Countries, 2nd edition; be alerted to the scope of major diseases; learn strategies to improve policies and choices to implement cost-effective interventions; and locate chapters of immediate interest."

The Influence of the Pharmaceutical Industry

The Influence of the Pharmaceutical Industry PDF Author: Great Britain: Parliament: House of Commons: Health Committee
Publisher: The Stationery Office
ISBN: 9780215024572
Category : Political Science
Languages : en
Pages : 556

Get Book Here

Book Description
Incorporating HC 1030-i to iii.

Managed Care Pharmacy Practice

Managed Care Pharmacy Practice PDF Author: Navarro
Publisher: Jones & Bartlett Publishers
ISBN: 076378883X
Category : Medical
Languages : en
Pages : 659

Get Book Here

Book Description
Managed Care Pharmacy Practice, Second Edition offers information critical to the development and operation of a managed care pharmacy program. The text also covers the changes that have taken place within the delivery of pharmacy services, as well as the evolving role of pharmacists.

Competition and the Cost of Medicare's Prescription Drug Program

Competition and the Cost of Medicare's Prescription Drug Program PDF Author: Anna Cook
Publisher:
ISBN: 9781457856631
Category :
Languages : en
Pages : 48

Get Book Here

Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.

Minutes of Proceedings and Evidence

Minutes of Proceedings and Evidence PDF Author: Canada. Parliament. House of Commons. Special Committee on Drug Costs and Prices
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1070

Get Book Here

Book Description